Alzheimer's drug Leqembi brought in approximately $19 million in sales for the quarter, up from the $10 million the drug generated last year. Read this story
Alzheimer's drug Leqembi brought in approximately $19 million in sales for the quarter, up from the $10 million the drug generated last year. Read this story
More from CNBC | Eisai Co Ltd Biogen Inc Business Biotechnology Biotech and Pharmaceuticals Pharmaceuticals Health care industry Breaking news Earnings business news cnbc Articles US: News Companies Business News Health & Science source:tagname:CNBC US Source